1. Home
  2. FSUN vs EVO Comparison

FSUN vs EVO Comparison

Compare FSUN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$38.93

Market Cap

966.0M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
EVO
Founded
1892
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.0M
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FSUN
EVO
Price
$38.93
$3.63
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$46.33
$7.00
AVG Volume (30 Days)
100.0K
213.1K
Earning Date
01-26-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
3.52
N/A
EPS
3.16
N/A
Revenue
$384,497,000.00
$887,396,457.00
Revenue This Year
$19.09
N/A
Revenue Next Year
$62.50
$8.52
P/E Ratio
$12.27
N/A
Revenue Growth
10.48
N/A
52 Week Low
$29.95
$2.84
52 Week High
$45.32
$4.80

Technical Indicators

Market Signals
Indicator
FSUN
EVO
Relative Strength Index (RSI) 57.37 60.22
Support Level $37.73 $3.58
Resistance Level $39.57 $3.87
Average True Range (ATR) 0.92 0.08
MACD -0.09 0.04
Stochastic Oscillator 56.99 67.09

Price Performance

Historical Comparison
FSUN
EVO

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: